Insiders Updates Analysts predict EYPT shares will perform strongly in 2023 Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Stock Earnings Taking a Closer Look At EyePoint Pharmaceuticals Inc (EYPT) Following Its Recent Trade EyePoint Pharmaceuticals Inc’s filing revealed that its Director Zaderej Karen L. acquired Company’s shares for reported $29950.0 on May 19
Analysts Viewpoint EyePoint Pharmaceuticals Inc [EYPT] Director makes an insider acquire of 5,000 shares worth 29,950. Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. EyePoint Pharmaceuticals
Stock Earnings Sharp decrease in EYPT’s short interest leads to decline in days-to-cover ratio Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its